Should the government cap prescription drug prices? | The Tylt
Three U.S. senators have launched a probe into why a 40-year-old cancer drug's price has increased 1400 percent. Introduced in 1976 to treat brain tumors and Hodgkin's lymphoma, one capsule of Lomustinecost $50 in 2013 and now the same dose costs $768. Critics say we can't allow unscrupulous profiteers to purchase drug patents and jack their prices out of reach of sick people who need them. But others say we must let the free market decide. Should the government cap drug prices? 💊
Should the government cap prescription drug prices?
Coronavirus: Coverage and Care